Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05909540
Other study ID # XW-NS-PNHBI
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date February 6, 2022
Est. completion date June 30, 2024

Study information

Verified date April 2023
Source Xuanwu Hospital, Beijing
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A Prospective Study of Natural History and Clinical Outcomes for Basilar Invagination


Description:

Since basilar invagination was reported, its pathogenesis has been considered both primary and secondary. Surgical treatment methods emerged in an endless stream, and a hundred schools of thought contend. However, the link between the symptoms and imaging has not been studied in detail. We prospectively enrolled patients with basilar depression, and then explored the natural history of the disease and the clinical outcomes of early intervention.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 200
Est. completion date June 30, 2024
Est. primary completion date December 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. BI discovered by the patient not incidentally; 2. Patients with depression of the skull base caused by congenital skeletal developmental malformations and symptoms; 3. The patient was initially treated in our center, and the interval between onset and treatment was at least 1 month or no treatment; 4. The imaging diagnosis of BI meets the standard (3-5mm higher than the Chamberlain's line) Exclusion Criteria: 1. secondary BI caused by trauma, pathological factors such as rheumatoid arthritis, hyperparathyroidism, osteogenesis imperfecta, rickets, osteomalacia, spinal cord tumors, tuberculosis, inflammation of adjacent structures, and simple AAD, odontoid body deformity, etc. 2. spinal vascular disease, intervertebral disc herniation, tethered spinal cord disease and other diseases that may cause symptoms. 3. Patients with incomplete imaging data or symptomatic data.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Posterior facet distraction and fusion
With the patient in prone position, cervical traction was only intraoperatively after anesthesia with weights of approximately 5-8 kg during surgery. Monitoring of the spinal cord with motor evoked potential and somatosensory evoked potential were used throughout the surgery. Using a posterior midline incision, the occiput to the C2 spinous process was surgically exposed, separated to the lateral edge of the C1-2 joint, and cut off at the C2 nerve root to expose the C1-2 articular surface Quantitative reduction techniques included the following steps .1) Facet joint release and cage implantation technique 2)Adjusting POCA by cantilever and occipitocervical fixation technique.

Locations

Country Name City State
China Xuanwu Hospital, Capital Medical University Beijing

Sponsors (1)

Lead Sponsor Collaborator
Xuanwu Hospital, Beijing

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary improved symptoms The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores) 1 months postoperatively
Primary improved symptoms The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores) 3 months postoperatively
Primary improved symptoms The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores) 6 months postoperatively
Primary improved radiology improved ADI, CCA, CTA ; The basilar invagination reduced 1 months postoperatively
Primary improved radiology improved ADI, CCA, CTA ; The basilar invagination reduced 3 months postoperatively
Primary improved radiology improved ADI, CCA, CTA ; The basilar invagination reduced 6 months postoperatively
Primary operation complication operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury ) 1 months postoperatively
Primary operation complication operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury ) 3 months postoperatively
Primary operation complication operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury ) 6 months postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT05754554 - Clinical Study of the Treatment of Chiari Malformation Combined With Type II Skull Base Depression N/A
Recruiting NCT05849363 - A Prospective Study of Surgical Treatment Strategies for Goal B Type Basilar Invagination N/A
Completed NCT04220541 - Investigation of the Effects of Exercise on Patients With Chiari Malformation N/A